HanYang University Medical Center (HYUMC) Registry

Hanyang University Seoul Hospital5,000 enrolled

Overview

The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry. The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.

In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.

Study Type

OBSERVATIONAL

Enrollment

5,000

Conditions

Coronary Artery Stenosis Coronary Artery Disease Blood Pressure

Interventions

percutaneous coronary interventionDEVICE

patients with CAD undergoing PCI with second generation DES

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea. Exclusion Criteria: * second or subsequent hospitalization records of patients with multiple admissions * patients who died during index hospitalization * patients who treated with first-generation drug eluting stent * patients with an outpatient follow-up record of less than 6 months * patients with insufficient medical records.

Locations (3)

Hanyang University Guri Hospital

Guri-si, South Korea

RECRUITING

Hanyang University Seoul Hospital

Seoul, South Korea

RECRUITING

Young-Hyo Lim

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

MACCE (major adverse cardiac and cerebrovascular event)

the composite of all-cause death, myocardial infarction, stroke, or any revascularization

Time frame: 10-year

Secondary Outcomes

All-cause death

death from any cause

Time frame: 10-year

Myocardial infarction,

presence of clinical symptoms with the presence of electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormalities, in conjunction with elevated levels of cardiac biomarker above the 99th percentile upper reference limit

Time frame: 10-year

Stroke

neurological deficit resulting from acute focal damage to the central nervous system due to a vascular cause, requiring hospitalization, and confirmed by a neurologist through imaging findings

Time frame: 10-year

Any revascularization

PCI or coronary artery bypass surgery on either target or nontarget vessels

Time frame: 10-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.